350 related articles for article (PubMed ID: 17562523)
1. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
4. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
5. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
6. Outcome of late-life depression after 3 years of sequential treatment.
Kok RM; Nolen WA; Heeren TJ
Acta Psychiatr Scand; 2009 Apr; 119(4):274-81. PubMed ID: 19053970
[TBL] [Abstract][Full Text] [Related]
7. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
Entsuah AR; Rudolph RL; Chitra R
Psychopharmacol Bull; 1995; 31(4):759-66. PubMed ID: 8851650
[TBL] [Abstract][Full Text] [Related]
10. Single-blind comparison of venlafaxine and nortriptyline in elderly major depression.
Gastó C; Navarro V; Marcos T; Portella MJ; Torra M; Rodamilans M
J Clin Psychopharmacol; 2003 Feb; 23(1):21-6. PubMed ID: 12544371
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
12. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
Janssen J; Hulshoff Pol HE; Schnack HG; Kok RM; Lampe IK; de Leeuw FE; Kahn RS; Heeren TJ
Int J Geriatr Psychiatry; 2007 May; 22(5):468-74. PubMed ID: 17357181
[TBL] [Abstract][Full Text] [Related]
13. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
Mahapatra SN; Hackett D
Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
[TBL] [Abstract][Full Text] [Related]
14. Early response as predictor of final remission in elderly depressed patients.
Kok RM; van Baarsen C; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2009 Nov; 24(11):1299-303. PubMed ID: 19322797
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic action lag time and resistance to treatment].
Peretti CS
Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
[TBL] [Abstract][Full Text] [Related]
17. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
Rosenberg C; Lauritzen L; Brix J; Jørgensen JB; Kofod P; Bayer LB
Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097
[TBL] [Abstract][Full Text] [Related]
18. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine: new preparation. Just another antidepressant.
Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
